The renewal of the National Cervical Screening Program

Jonathan Carter, Ian Hammond and Megan Smith
Med J Aust 2017; 206 (6): . || doi: 10.5694/mja16.01257
Published online: 3 April 2017

The renewed National Cervical Screening Program (NCSP) will use 5-yearly oncogenic human papillomavirus (HPV) testing and partial genotyping with reflex liquid-based cytology. There is overwhelming evidence from prospective randomised trials that primary HPV screening is vastly superior to cytology testing alone.1,2 The renewal is based on recommendations of the Australian Medical Services Advisory Committee (MSAC) following a robust and transparent process involving a commissioned evidence review and health outcome and economic modelling.3

  • Jonathan Carter1
  • Ian Hammond2
  • Megan Smith3,4

  • 1 Chris O'Brien Lifehouse, Sydney, NSW
  • 2 University of Western Australia, Perth, WA
  • 3 Cancer Council NSW, Sydney, NSW
  • 4 University of Sydney, Sydney, NSW


Competing interests:

No relevant disclosures.


remove_circle_outline Delete Author
add_circle_outline Add Author

Do you have any competing interests to declare? *

I/we agree to assign copyright to the Medical Journal of Australia and agree to the Conditions of publication *
I/we agree to the Terms of use of the Medical Journal of Australia *
Email me when people comment on this article

Responses are now closed for this article.